文献速递湿疹皮炎与荨麻疹

基于五出生队列的湿疹聚类及其与丝聚蛋白突变和特应性共病关联分析

Identification of eczema clusters and their association with filaggrin and atopic comorbidities: analysis of five birth cohorts.
PubMed 文献 · Br J Dermatol · 2023-01-01

该研究利用五个出生队列共7464名参与者的多维湿疹发作变量(持续时间、时序、持续/复发程度),通过PAM聚类识别出五个稳定湿疹轨迹集群:无湿疹、早期短暂、晚发、间歇和持续型。各集群与FLG突变及特应性致敏的关联强度不同,持续型与FLG突变关联最强(RRR 2.70)。

要点

  • 多维纵向变量可识别出五个稳定且内部同质的湿疹轨迹集群。
  • 持续型湿疹与FLG突变关联最强(RRR 2.70),间歇型次之(RRR 2.29)。
  • 晚发型湿疹与FLG突变及父母湿疹均无显著关联,提示不同遗传架构。

核心结论

  • 多维变量聚类可识别出稳定、内部同质的湿疹轨迹集群,且不同集群具有不同的遗传架构。
  • 同质症状集群不一定由完全独特的机制驱动。

研究设计与样本

  • 五个出生队列的纵向数据分析,纳入7464名具有完整数据的参与者。
  • 从出生至18岁提取六个维度的湿疹发作变量(持续时间、时序、持续/复发程度等),在5个年龄段(婴儿期、幼儿期、学龄前/学龄早期、童年中期、青春期)定义发作。
  • 采用围绕中心点划分(PAM)聚类法推导湿疹时间模式集群,并评估稳定性、同质性及包括FLG突变在内的风险因素关联。

主要发现

  • 识别出五个集群:无湿疹(51.0%)、早期短暂性湿疹(21.6%)、晚发型湿疹(8.1%)、间歇性湿疹(7.5%)和持续性湿疹(11.8%)。
  • 完整数据与插补数据(n=15 848)的集群分配高度一致(调整兰德指数=0.99),集群非常稳定。
  • 父母湿疹与除晚发型外的所有集群相关;吸入性过敏原致敏与所有集群相关,持续性湿疹风险最高。
  • 除晚发型外,所有集群均与FLG突变相关;持续性湿疹关联最强(RRR 2.70,95%CI 2.24-3.26;P<0.001),间歇性湿疹次之(RRR 2.29,95%CI 1.82-2.88;P<0.001)。

临床怎么用

  • 临床可借助多维纵向信息(持续时间、时序、复发模式)区分湿疹轨迹集群,而非仅凭有无湿疹。
  • 持续性湿疹和间歇性湿疹患者应关注FLG突变相关风险,晚发型湿疹需考虑非FLG相关机制。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Longitudinal modelling of the presence/absence of current eczema through childhood has identified similar phenotypes, but their characteristics often differ between studies. OBJECTIVES: To demonstrate that a more comprehensive description of longitudinal pattern of symptoms may better describe trajectories than binary information on eczema presence. METHODS: We derived six multidimensional variables of eczema spells from birth to 18 years of age (including duration, temporal sequencing and the extent of persistence/recurrence). Spells were defined as consecutive observations of eczema separated by no eczema across 5 epochs in five birth cohorts: infancy (first year); early childhood (age 2-3 years); preschool/early school age (4-5 years); middle childhood (8-10 years); adolescence (14-18 years). We applied Partitioning Around Medoids clustering on these variables to derive clusters of the temporal patterns of eczema. We then investigated the stability of the clusters, within-cluster homogeneity and associated risk factors, including FLG mutations. RESULTS: Analysis of 7464 participants with complete data identified five clusters: (i) no eczema (51.0%); (ii) early transient eczema (21.6%); (iii) late-onset eczema (LOE; 8.1%); (iv) intermittent eczema (INT; 7.5%); and (v) persistent eczema (PE; 11.8%). There was very-high agreement between the assignment of individual children into clusters when using complete or imputed (n = 15 848) data (adjusted Rand index = 0.99; i.e. the clusters were very stable). Within-individual symptom patterns across clusters confirmed within-cluster homogeneity, with consistent patterns of symptoms among participants within each cluster and no overlap between the clusters. Clusters were characterized by differences in associations with risk factors (e.g. parental eczema was associated with all clusters apart from LOE; sensitization to inhalant allergens was associated with all clusters, with the highest risk in the PE cluster). All clusters apart from LOE were associated with FLG mutations. Of note, the strongest association was for PE [relative risk ratio (RRR) 2.70, 95% confidence interval (CI) 2.24-3.26; P < 0.001] followed by INT (RRR 2.29, 95% CI 1.82-2.88; P < 0.001). CONCLUSIONS: Clustering of multidimensional variables identified stable clusters with different genetic architectures. Using multidimensional variables may capture eczema development and derive stable and internally homogeneous clusters. However, deriving homogeneous symptom clusters does not necessarily mean that these are underpinned by completely unique mechanisms.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Haider S, Granell R, Curtin JA, et al. Identification of eczema clusters and their association with filaggrin and atopic comorbidities: analysis of five birth cohorts. Br J Dermatol. 2023. PMID: 37935633. doi:10.1093/bjd/ljad326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。